Interaction of nitric oxide and renin angiotensin system in pulmonary arterial circulation of RHR

Archives of Pharmacal Research

Volumn 20, Issue 5, 1997, Pages 389-395

  Lee, Byung Ho ^a   Shin, Hwa Sup ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Endothelium; Losartan; Nitric oxide; Renal hypertensive rat; Renin angiotensin system

Indexed keywords

EID: 20544469205     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02973928     Document Type: Article

References (26)

1. DeGraaf, G. L., Pals, D. T., Couch, S. J., and Lawson, J. A., Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates. J. Pharmacol. Exp. Ther., 264, 6-10 (1993).
2. Gardes, J., Gonzalez, M. F., Alhenc Gelas, F., and Menard, J., Influence of sodium diet on L-NAME effects on renin release and renal vasoconstriction. Am. J. Physiol., 267, F798-804 (1994).
3. Guan, H., Cachofeiro, V., Pucci, M. L., Kaminski, P. M., Wolin, M. S., and Nasjletti, A., Nitric oxide and the depressor response to angiotensin blockade in hypertension. Hypertension, 27, 19-24 (1996).
4. Haber, E., Koerner, T., Page, L. B., Kliman, B., and Purnode, A., Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J. Clin. Endocrinol. Metab., 29, 1349-1355 (1969).
5. Haberl, R. L., Decker, P. J., and Einhaupl, K. M., Angiotensin degradation products mediate endothelium-dependent dilation of the rabbit brain arterioles. Circ. Res., 68, 1621-1627 (1991).
6. Henderson, A. H., Vascular endothelium in ischemic heart disease: possible role for endothelium-derived relaxing factor.Cardiovasc. Drugs Ther., 3 (Suppl 1), 241-248 (1989).
7. Higashi, Y., Oshima, T., Ono, N., Hiraga, H., Yoshimura, M., Watanabe, M., Matsuura, H., Kambe, M., and Kajiyama, G., Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans. J. Clin. Endocrinol. Metab., 80, 2198-2202 (1995).
8. Ignarro, L. J., Endothelium-derived nitric oxide: actions and properties. FASEB J., 3, 31-36 (1989).
9. Ito, S., Johnson, C. S., and Carretero, O. A., Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J. Clin. Invest., 87, 1656-1663 (1991).
10. Knowles, R. G. and Moncada, S., Nitric oxide as a signal in blood vessels. Trends. Biochem. Sci., 17, 399-402 (1992).
11. Lee, B. H., Shin, H. S., Huh, I. H., Ann, H. S., and Roh, J. K., Angiotensin II reactivity in systemic and pulmonary arterial system of acute renal hypertensive rats. Yakhak Hoeji, 37, 605-614 (1993a).
12. Lee, B. H., Shin, H. S., and Huh, I. H., Differential function of EDRF in systemic arterial and pulmonary arterial system of renal hypertensive rats. Korean J. Pharmacol, 29, 213-223 (1993b).
13. 1 receptor antagonists in rats. Arch. Pharm. Res., 17, 263-268 (1994).
14. Lee, B. H. and Shin, H. S., Interaction of nitric oxide and renin angiotensin system in renal hypertensive rats. Jpn. J. Pharmacol., 74, 83-90 (1997).
15. Moncada, S., Palmer, R. M., and Higgs, E. A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142 (1991).
16. Ohishi, K., Carmines, P. K., Inscho, E. W., and Navar, L. G., EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am. J. Physiol., 263, F900-F906 (1992).
17. Prince, R. C. and Gunce, D. E., Rising interesst in nitric oxide synthase. Trends. Biochem. Sci., 18, 35-36 (1993).
18. Rees, D. D., Palmer, R. M., Schulz, R., Hodson, H. F., and Moncada, S., Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752 (1990).
19. Ruilope, L. M., Lahera, V., Rodicio, J. L., and Romero, J. C., Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J. Hypertens., 12, 625-631 (1994).
20. Scholz, H. and Kurtz, A., Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney. J. Clin. Invest., 91, 1088-1094 (1993).
21. Schricker, K., Hegyi, I., Hamann, M., Kaissling, B., and Kurtz, A., Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II. Proc. Natl. Acad. Sci., U.S.A., 92, 8006-8010 (1995).
22. Sudhir, K., MacGregor, J. S., Gupta, M., Barbant, S. D., Redberg, R., Yock, P. G., and Chatterjee, K., Effect of selective angiotesin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies. Circulation, 87, 931-938 (1993).
23. Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., and Smith, R. D., Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev., 45, 205-251 (1993).
24. Van de Voorde, J. and Leusen, I., Endothelium-dependent and independent relaxation of aortic rings from hypertensive rats. Am. J. Physiol., 250, H711-H717 (1986).
25. Vidal, M. J., Romero, J. C., and Vanhoutte, P. M., Endothelium-derived relaxing factor inhibits renin release. Eur. J. Pharmacol., 149, 401-402 (1988).
26. Zhang, J., Pfaffendorf, M., Zhang, J. S., and van Zwieten, P. A., Influence of the vascular endothelium on angiotensin II-induced contractions in rabbit renal artery. Fundam. Clin. Pharmacol., 9, 25-29 (1995).